{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:34Z","timestamp":1786119094931,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/iae.0b013e31816b3192","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T14:39:15Z","timestamp":1236263955000},"page":"987-995","source":"Crossref","is-referenced-by-count":29,"title":["Periocular Triamcinolone for Prevention of Macular Edema After Iodine 125 Plaque Radiotherapy of Uveal Melanoma"],"prefix":"10.1097","volume":"28","author":[{"given":"Noel","family":"Horgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz F.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Materin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"O\u2019Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/bjo.87.11.1370","article-title":"Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years\u2019 experience.","volume":"87","author":"Bartlema","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3928\/1542-8877-19980501-08","article-title":"Radiation therapy for uveal malignant melanoma.","volume":"29","author":"Shields","year":"1998","journal-title":"Ophthalmic Surg Lasers"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archopht.120.7.933","article-title":"Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients.","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","article-title":"Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R5-11-20210130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","article-title":"Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement.","volume":"127","author":"Gunduz","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archopht.117.5.609","article-title":"Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma.","volume":"117","author":"Gunduz","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R7-11-20210130","first-page":"1038","article-title":"Principles and Practice of Ophthalmology.","volume":"2","author":"Mukai","year":"1994"},{"key":"R8-11-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IAE.0b013e31814b1b75","article-title":"Early macular morphological changes following plaque radiotherapy for uveal melanoma.","volume":"28","author":"Horgan","year":"2008","journal-title":"Retina"},{"key":"R9-11-20210130","first-page":"71","article-title":"Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema.","volume":"39","author":"Yoshikawa","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ajo.2004.09.038","article-title":"Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.","volume":"139","author":"Bakri","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for macular edema, Early Treatment Diabetic Retinopathy Study report number 1.","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0161-6420(82)34611-4","article-title":"Radiation retinopathy.","volume":"89","author":"Brown","year":"1982","journal-title":"Ophthalmology"},{"key":"R13-11-20210130","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0161-6420(82)34612-6","article-title":"Radiation optic neuropathy.","volume":"89","author":"Brown","year":"1982","journal-title":"Ophthalmology"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0039-6257(04)00109-2","article-title":"Macular edema.","volume":"49","author":"Tranos","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0161-6420(92)31832-9","article-title":"Radiation maculopathy after proton beam irradiation for choroidal melanoma.","volume":"99","author":"Guyer","year":"1992","journal-title":"Ophthalmology"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"R17-11-20210130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.","volume":"113","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"key":"R18-11-20210130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.2004.041707","article-title":"Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.","volume":"88","author":"Ciardella","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2004.12.054","article-title":"Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone.","volume":"139","author":"Larsson","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R20-11-20210130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1034\/j.1600-0420.2003.00176.x","article-title":"Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.","volume":"81","author":"Degenring","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/bjo.87.8.968","article-title":"Trans-Tenon\u2019s retrobulbar triamcinolone infusion for the treatment of uveitis.","volume":"87","author":"Okada","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R22-11-20210130","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00006982-200412000-00020","article-title":"Trans-Tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion.","volume":"24","author":"Wakabayashi","year":"2004","journal-title":"Retina"},{"key":"R23-11-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73759-6","article-title":"The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.","volume":"120","author":"Helm","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R24-11-20210130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ophtha.2004.12.039","article-title":"Posterior sub-Tenon\u2019s capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.","volume":"112","author":"Tunc","year":"2005","journal-title":"Ophthalmology"},{"key":"R25-11-20210130","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1124\/jpet.105.092353","article-title":"The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling.","volume":"315","author":"Uckermann","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R26-11-20210130","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/archopht.122.12.1801","article-title":"Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.","volume":"122","author":"Brooks","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R27-11-20210130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","article-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.","volume":"80","author":"Edelman","year":"2005","journal-title":"Exp Eye Res"},{"key":"R28-11-20210130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1600-0420.2005.00438.x","article-title":"Intravitreal triamcinolone acetonide for refractory uveitic cystoid macular oedema: long-term management and outcome.","volume":"83","author":"Angunawela","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"R29-11-20210130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/bjo.85.5.625b","article-title":"Echographic localisation of corticosteroid after retrobulbar injection.","volume":"85","author":"Tolentino","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R30-11-20210130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9394(21)00232-4","article-title":"Echographic localization of corticosteroids after periocular injection.","volume":"103","author":"Freeman","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"R31-11-20210130","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0161-6420(97)30065-7","article-title":"A comparison of retrobulbar versus sub-Tenon\u2019s corticosteroid therapy for cystoid macular edema refractory to topical medications.","volume":"104","author":"Thach","year":"1997","journal-title":"Ophthalmology"},{"key":"R32-11-20210130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ajo.2006.05.023","article-title":"Intravitreal triamcinolone acetonide concentration after subtenon injection.","volume":"142","author":"Thomas","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R33-11-20210130","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ajo.2004.12.087","article-title":"Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.","volume":"139","author":"Hayashi","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R34-11-20210130","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1167\/iovs.05-0297","article-title":"Intravitreal injection versus sub-Tenon\u2019s infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.","volume":"46","author":"Bonini-Filho","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-11-20210130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ophtha.2006.02.027","article-title":"Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.","volume":"113","author":"D\u2019Amico","year":"2006","journal-title":"Ophthalmology"},{"key":"R36-11-20210130","first-page":"1289","article-title":"Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor\/vascular permeability factor.","volume":"147","author":"Vinores","year":"1995","journal-title":"Am J Pathol"},{"key":"R37-11-20210130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B","article-title":"Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.","volume":"186","author":"Stitt","year":"1998","journal-title":"J Pathol"},{"key":"R38-11-20210130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00008390-199910000-00003","article-title":"Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines.","volume":"9","author":"Ijland","year":"1999","journal-title":"Melanoma Res"},{"key":"R39-11-20210130","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/bjo.84.7.750","article-title":"Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.","volume":"84","author":"Sheidow","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R40-11-20210130","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archopht.124.10.1428","article-title":"Vascular endothelial growth factor a in eyes with uveal melanoma.","volume":"124","author":"Missotten","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R41-11-20210130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.86.4.448","article-title":"Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.","volume":"86","author":"Boyd","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R42-11-20210130","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen.","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"R43-11-20210130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.2479987","article-title":"Vascular permeability factor, an endothelial cell mitogen related to PDGF.","volume":"246","author":"Keck","year":"1989","journal-title":"Science"},{"key":"R44-11-20210130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress.","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"R45-11-20210130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V","article-title":"Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.","volume":"43","author":"Lundberg","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R46-11-20210130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/cyto.1999.0557","article-title":"Corticosteroids and interferons inhibit cytokine-induced production of IL-8 by human endothelial cells.","volume":"12","author":"Nyhlen","year":"2000","journal-title":"Cytokine"},{"key":"R47-11-20210130","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1167\/iovs.04-0905","article-title":"Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.","volume":"46","author":"Tamura","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-200807000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:46:00Z","timestamp":1786038360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200807000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31816b3192","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}